VIKING THERAPEUTICS INC (VKTX:NASDAQ)
$31.66 0.86 (2.7922%)
Analysed VIKING THERAPEUTICS INC (VKTX:NASDAQ) News Sources
Three Biotechs That Are Top Takeover Targets
18-05-2026
247wallst.com
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party
19-05-2026
fool.com
Viking Therapeutics to Participate at Upcoming Investor Conferences
21-05-2026
yahoo.com
Could Viking Therapeutics Be the Next Eli Lilly?
21-05-2026
fool.com
2 Stocks That Could Realistically Double by 2030
22-05-2026
fool.com
Is Viking Therapeutics a Top Takeover Target?
23-05-2026
fool.com
Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know.
25-05-2026
fool.com
A Look At Viking Therapeutics (VKTX) Valuation As Shares Show Mixed Recent Returns
25-05-2026
yahoo.com
Don't Buy Viking Therapeutics Stock Until You Read This
26-05-2026
fool.com
If Viking Therapeutics Is Acquired, Here’s Who Wins
26-05-2026
247wallst.com
What is the current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ) is $31.66.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is $0.86.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is 2.7922%.
What is the most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is .
SEC-8K** Filing Available For VIKING THERAPEUTICS INC (VKTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.